Effect of miR-143-3p on C2C12 myoblast differentiationFootnote

Abbreviations: MyoD, Myogenic differentiation; myf5, myogenic factor 5; ACTA1, Actin-α 1; MyoG, Myogenin; MRF4, Myogenic regulatory factor 4; MyHC, Myosin heavy chain; Wnt5a, Wingless-type family member 5a; LRP5, Low-density lipoprotein receptor-related protein 5; Axin2, Axis formation inhibitor 2; β-catenin, Beta-catenin.

References

• Soares RJ, Cagnin S, Chemello F, et al. Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions. J. Biol. Chem. 2014;289:21909–21925.10.1074/jbc.M114.561845
   PubMed Web of Science ®Google Scholar
• Tidyman WE, Moore LA, Bandman E. Expression of fast myosin heavy chain transcripts in developing and dystrophic chicken skeletal muscle. Dev. Dyn. 1997;208:491–504.10.1002/(ISSN)1097-0177
   PubMed Web of Science ®Google Scholar
• Kuang S, Kuroda K, Le Grand F, et al. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 2007;129:999–1010.10.1016/j.cell.2007.03.044
   PubMed Web of Science ®Google Scholar
• Tapscott SJ. The circuitry of a master switch: myod and the regulation of skeletal muscle gene transcription. Development. 2005;132:268526–268595.
   Web of Science ®Google Scholar
• Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clinical genetics. 2000;57:16–25.
   PubMed Web of Science ®Google Scholar
• Kaindl A, Rüschendorf F, Krause S, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J. Med. Genet. 2004;41:842–848.10.1136/jmg.2004.020271
   PubMed Web of Science ®Google Scholar
• Laing NG, Dye DE, Wallgren-Pettersson C, et al. Mutations and polymorphisms of the skeletal muscle α-actin gene (ACTA1). Human Mutation. 2009;30:1267–1277.10.1002/humu.v30:9
   PubMed Web of Science ®Google Scholar
• Pereira JASA, Wessels A, Nijtmans L, et al. New method for the accurate characterization of single human skeletal muscle fibres demonstrates a relation between mATPase and MyHC expression in pure and hybrid fibre types. J. Muscle Res. Cell Motil. 1995;16:21–34.
   PubMed Web of Science ®Google Scholar
• Borello U, Coletta M, Tajbakhsh S, et al. Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. Development. 1999;126:4247–4255.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Terada K, Nohno T. Canonical Wnt signaling is involved in switching from cell proliferation to myogenic differentiation of mouse myoblast cells. J. Mol. Signaling. 2011;6:12.10.1186/1750-2187-6-12
   PubMedGoogle Scholar
• Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation. J. Cell Biol. 2003;162:899–908.10.1083/jcb.200303158
   PubMed Web of Science ®Google Scholar
• Snyder CM, Rice AL, Estrella NL, et al. MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration. Development. 2013;140:31–42.10.1242/dev.081851
   PubMed Web of Science ®Google Scholar
• Ke Y, Zhao W, Xiong J, et al. miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1. Biochem. Res. Int. 2013;2013:1–8.
   Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev. Cell. 2006;11:441–450.10.1016/j.devcel.2006.09.009
   PubMed Web of Science ®Google Scholar
• Lauressergues D, Couzigou J-M, San Clemente H, et al. Primary transcripts of microRNAs encode regulatory peptides. Nature. 2015;520:90–93.
   PubMed Web of Science ®Google Scholar
• Zhang N, Wei X, Xu L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett. 2013;587:2346–2351.10.1016/j.febslet.2013.05.059
   PubMed Web of Science ®Google Scholar
• Yang G, Wu D, Zhu J, et al. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol. Rep. 2013;30:877–889.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705–710.
   PubMed Web of Science ®Google Scholar
• Sun X, He Y, Huang C, et al. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway. Cell. Signalling. 2013;25:2805–2811.10.1016/j.cellsig.2013.09.006
   PubMed Web of Science ®Google Scholar
• Esau C, Kang X, Peralta E, et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004;279:52361–52365.10.1074/jbc.C400438200
   PubMed Web of Science ®Google Scholar
• Yi C, Xie W, Li F, et al. MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin. FEBS Lett. 2011;585:3303–3309.10.1016/j.febslet.2011.09.015
   PubMed Web of Science ®Google Scholar
• Deacon DC, Nevis KR, Cashman TJ, et al. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development. 2010;137:1887–1896.10.1242/dev.050526
   PubMed Web of Science ®Google Scholar
• Wang L, Chen X, Zheng Y, et al. MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms. Exp. Cell. Res. 2012;318:2324–2334.10.1016/j.yexcr.2012.06.018
   PubMed Web of Science ®Google Scholar
• Dey BK, Gagan J, Yan Z, et al. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 2012;26:2180–2191.
   PubMed Web of Science ®Google Scholar
• Alexander M, Kawahara G, Motohashi N, et al. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death and Differentiation. 2013;20:1194–1208.
   PubMed Web of Science ®Google Scholar
• Chen X, Huang Z, Chen D, et al. Role of microRNA-27a in myoblast differentiation. Cell. Biol. Int. 2014;38:266–271.10.1002/cbin.v38.2
   PubMed Web of Science ®Google Scholar
• Huang Z, Chen X, Yu B, et al. MicroRNA-27a promotes myoblast proliferation by targeting myostatin. Biochem. Biophys. Res. Commun. 2012;423:265–269.10.1016/j.bbrc.2012.05.106
   PubMed Web of Science ®Google Scholar
• Tajbakhsh S, Borello U, Vivarelli E, et al. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development. 1998;125:4155–4162.
   PubMed Web of Science ®Google Scholar